Cresset Targets Global Growth with New India HQ

Cresset Targets Global Growth with New India HQ

Cambridge, UK May 2024 - Cresset, an innovative provider of solutions for Computational Drug Discovery and Development that accelerate research outcomes, is expanding its existing Asia Pacific presence by creating a new headquarters in Bangalore, one of India’s leading centers for biotechnology and pharmaceutical research. 

This latest announcement consolidates Cresset’s position as a global player in the drug discovery space, and comes off the back of establishing a new facility in Boston earlier in the year. 

From its origins in the UK, Cresset has grown into a drug discovery solutions company with a genuine global reach, with more than 60% of its revenues now coming from outside the UK. The company has experienced rapid growth in recent years, achieving an average year-on-year growth of over 25% and a significant increase in its employee headcount since 2020.

Cresset’s new India site will support the growing demands of Cresset’s APAC customer base, and increase its reach in a range of markets across the region, including South Korea, Japan, China, and Australasia.

Bangalore’s status as one of the top locations in the industry will enable Cresset to tap into the wealth of computational chemistry talent available on its doorstep, and be closer to its customer base. The new staff appointments in India will span a range of areas, including sales, support, and development.

Commenting on the new Indian HQ Cresset’s Chief Scientific Officer  and co-Founder Dr. Mark Mackey said “Launching our new site in India marks a major milestone in our international growth and expansion as a company. The talent pool and centers of excellence available in the region will enable us to expand our existing service offering to clients and develop strong relationships through face-to-face contact on the ground.

“We already have a satellite office space in Bangalore, where a high proportion of our Indian staff are currently based. The new office will allow us to grow our overall business and gain access to grant funding in the Indian market”

As part of their work in India, Cresset’s Chief Scientific Officer Mark Mackey and Commercial Director David Bardsley will be attending the Indian Conference for Academics in Dehli on Tuesday 14th May 2024. The conference will cover a range of issues in the field of computational chemistry. You can find further details here

-Ends-

Contact

Andrew Hair, PR Manager, remarketing, andrew.hair@ramarketingpr.com, +44 0191 222 1242

About Cresset

Chemists in the world’s leading research organizations use Cresset solutions to discover, design, optimize, synthesize, and track the best small molecules. Our patented CADD Software, collaborative Torx® DMTA design-make-test-analyze platform, and expert Discovery CRO scientists, enable chemists to enhance efficiency and win the race to scientific success in industry sectors including pharmaceuticals, agrochemicals, fine chemicals and flavors, and fragrances. www.cresset-group.com